Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001487551 | SCV001692042 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001820186 | SCV002069500 | likely benign | not specified | 2021-11-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501674 | SCV002808455 | likely benign | Age related macular degeneration 9; Atypical hemolytic-uremic syndrome with C3 anomaly; Complement component 3 deficiency | 2021-07-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003948422 | SCV004760275 | likely benign | C3-related disorder | 2019-04-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |